John Hardesty Bland, MD, professor of medicine emeritus at the University of Vermont College of Medicine in Burlington, died on March 15, 2007. He was midway through his 90th year, fulfilling the prescription of his last book, Live Long, Die Fast: Playing the Aging Game to Win, published when he was 80. A consummate rheumatologist and wonderful bedside doctor and teacher, Dr. Bland was also one of the genuine polymaths in the American medical world.
Search results for: musculoskeletal disease
Increase NIH Funding, Participate in Advocates for Arthritis
The ACR consistently urges Congress to support issues relating to rheumatologists, rheumatology health professionals, and patients. The primary advocacy goals are: supporting of the “Arthritis Prevention, Control, and Cure Act of 2007” (H.R.1283/S.626) and the “Access to Medicare Imaging Act of 2007” (H.R.1293/S.1338), finding a permanent solution to the Medicare reimbursement issue, and increasing funding for the National Institutes of Health (NIH)—including the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Allergy and Infectious Diseases—and other agencies, such as the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the Department of Veterans Affairs’ Medical and Prosthetic Research Program.
European Beacon for Rheumatology
Josef S. Smolen, MD, led the way for outcomes measures and a scientifically based training program
Rehabilitation and Myositis
Physical therapy to manage inflammatory muscle disease
ARHP in 2008
As I begin my presidency, let me thank you—the ARHP membership—for allowing me to steer this organization through the 2008 year. As a physical therapist in clinical practice for more than 25 years, I have experienced the challenges of treating people with arthritis and rheumatic diseases. For the past 13 years, I have served the ARHP in various capacities and, as my personal involvement in the ARHP has grown, my knowledge of this premier rheumatology organization has also expanded.
Is Your Office Lab Up to Par?
Rheumatology practices with laboratory testing facilities in their offices can offer important benefits to patients and physicians. During their care of patients with musculoskeletal and rheumatic diseases, rheumatologists may order many tests, including erythrocyte sedimentation rate, synovial fluid analysis, complete blood count, fecal occult test, and urinalysis. While the prompt receipt of test results and the capability to evaluate specimens in the office directly improves efficiency, it is important to remember that offices must be certified to perform laboratory testing, particularly high-complexity tests such as the analysis of synovial fluids.
Enhanced Opportunities at the 2007 Meeting
The AMPC is using more translational components as a way of increasing the basic scientist’s interaction with clinicians, he explains. In keeping with this, the meeting will offer sessions on osteoclasts, implications for the development and treatment of osteoarthritis, T-cell subsets, and a year in review – all of which will be of interest to both the clinician and the basic researcher.
A Better Family Plan
How to minimize the risks of pregnancy for women with SLE
Disappearing Dollars
What’s happening to federal research funding in rheumatology?
Art and Medicine Converge for the Klemperer Lecture
Growing up in Brooklyn, N.Y., Paul H. Plotz, MD, often enjoyed an exciting game of stoopball with friends. Young Plotz took turns beaming a ball at the corner of his stoop, stopping occasionally to allow his father’s patients to enter the front door of his house, which also doubled as his father’s office.